Grantham, Mayo, Van Otterloo & Co (GMO)’s Celgene Corp CELG Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-296,000	Closed	-$27.9M	–	821
2019 Q1	$27.9M	Buy	+296,000	New	+$25.9M	0.2%	72

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CELG Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 729,700 shares — an estimated $72.5M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $72.5M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 729,700 Celgene Corp shares in Q4 2019, an estimated $72.5M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Celgene Corp position peaked at $72.5M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.